Rusckowski Stephen H's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Jul 30, 2021
- Accession no.
- 0001022079-21-000117
- Filed
- Jul 30, 2021
- Trade date
- Jul 28-29, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $20.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rusckowski Stephen HCIK 0001142624 | Director, Officer (Chairman, CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Common Stock | MOption exerciseAcquired | +139,751 | $95.80 | +$13,388,145.8 | 424,178 | Direct | |
| Jul 28, 2021 | Common Stock | SSaleDisposed | −139,751 | $140.14F2 | −$19,584,705.14 | 284,427 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseAcquired | +5,300 | $95.80 | +$507,740 | 289,727 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −5,300 | $140.59F3 | −$745,127 | 284,427 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseAcquired | +4,193 | $95.80 | +$401,689.4 | 288,620 | Direct | |
| Jul 29, 2021 | Common Stock | SSaleDisposed | −4,193 | $141.22F4 | −$592,135.46 | 284,427 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2021 | Common Stock | MOption exerciseDisposed | −139,751 | $95.80 | −$13,388,145.8 | 9,493 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseDisposed | −5,300 | $95.80 | −$507,740 | 4,193 | Direct | |
| Jul 29, 2021 | Common Stock | MOption exerciseDisposed | −4,193 | $95.80 | −$401,689.4 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.